keyword
https://read.qxmd.com/read/38629066/the-role-and-mechanism-of-txndc5-in-disease-progression
#21
REVIEW
Mingxia Jiao, Yeyong Zhang, Xie Song, Bing Xu
Thioredoxin domain containing protein-5 (TXNDC5), also known as endothelial protein-disulfide isomerase (Endo-PDI), is confined to the endoplasmic reticulum through the structural endoplasmic reticulum retention signal (KDEL), is a member of the PDI protein family and is highly expressed in the hypoxic state. TXNDC5 can regulate the rate of disulfide bond formation, isomerization and degradation of target proteins through its function as a protein disulfide isomerase (PDI), thereby altering protein conformation, activity and improving protein stability...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38628359/case-report-of-a-ruptured-right-atrial-aneurysm-in-a-child-and-a-comprehensive-literature-review
#22
Jie Zhou, Hao Xin, Qiao Li, Mei Zhu
BACKGROUND: The right atrial aneurysm is a rare cardiac malformation of unknown origin. It is typically asymptomatic but can occasionally lead to life-threatening and serious complications. CASE DESCRIPTION: We present a case of a right atrial aneurysm in an eight-year-old child who experienced complications including rupture of the atrial aneurysm, thrombosis, and recurrent large pericardial effusions over a one-month period. Following surgical treatment, the child had a favorable prognosis...
2024: Frontiers in Pediatrics
https://read.qxmd.com/read/38627663/clinical-phenotypes-of-comorbidities-in-end-stage-knee-osteoarthritis-a-cluster-analysis
#23
JOURNAL ARTICLE
Jun Ma, Kai Zhang, Xilong Ma, Hao Wang, Chao Ma, Yahui Zhang, Ruiyu Liu
OBJECTIVES: Comorbidities, as components of these heterogeneous features, often coexist with knee osteoarthritis, and are particularly prevalent in end-stage knee osteoarthritis. Here, we attempted to identify the different clinical phenotypes of comorbidities in patients with end-stage knee osteoarthritis by cluster analysis. METHODS: A total of 421 inpatients diagnosed with end-stage knee osteoarthritis who underwent inpatient surgery were included in this cross-sectional study...
April 17, 2024: BMC Musculoskeletal Disorders
https://read.qxmd.com/read/38627240/prosthetic-infections-following-tocilizumab-treatment-in-patients-with-rheumatoid-arthritis
#24
JOURNAL ARTICLE
A Louters, M Van Oosterhout, L Burgemeister, N T Jessurun, J A Van Lint
No abstract text is available yet for this article.
April 16, 2024: Rheumatology
https://read.qxmd.com/read/38626740/transcatheter-closure-of-atrial-septal-defects-with-absent-aortic-rim-and-the-predictors-of-right-atrial-reverse-remodelingtranscatheter-closure-of-atrial-septal-defects-with-absent-aortic-rim-and-the-predictors-of-right-atrial-reverse-remodeling-5-years-experience
#25
JOURNAL ARTICLE
Mingfei Li, Dawei Lin, Jianing Fan, Feng Zhang, Wenzhi Pan, Daxin Zhou, Junbo Ge
UNLABELLED: 【Abstract】 Aim: To investigate the safety of interventional therapy in patients with secondary atrial septal defect (atrial septal defect, ASD) with complete aortic rim deficiency and explore the predictors of right atrial non-reverse remodeling. METHODS: 1011 patients with ASD who underwent transcatheter closure in the Department of Cardiology, Zhongshan Hospital affiliated to Fudan University from June 2017 to June 2022 were enrolled in the study...
April 16, 2024: Cardiology
https://read.qxmd.com/read/38626545/reniformin-a-suppresses-non-small-cell-lung-cancer-progression-by-inducing-tlr4-nlrp3-caspase-1-gsdmd-dependent-pyroptosis
#26
JOURNAL ARTICLE
Huiyu Zhu, Yifei Guan, Wei Wang, Xinhui Liu, Sijia Wang, Ran Zheng, Yihan Li, Lei Liu, Hua Huang
Pyroptosis is an inflammatory form of programmed cell death that plays an important role in regulating tumor progression. Reniformin A (RA) is a natural compound isolated from the medicinal herb Isodon excisoides that has been applied as folk medicine in the treatment of esophageal cancer. However, whether RA has an individual function in cancer and the molecular mechanisms remain unclear. Here, we show that in non-small-cell lung cancer (NSCLC), RA inhibits tumor growth by functioning as a pyroptosis inducer to promote TLR4/NLRP3/caspase-1/GSDMD axis...
April 15, 2024: International Immunopharmacology
https://read.qxmd.com/read/38626509/a-multi-instance-tumor-subtype-classification-method-for-small-pet-datasets-using-ra-dl-attention-module-guided-deep-feature-extraction-with-radiomics-features
#27
JOURNAL ARTICLE
Zhaoshuo Diao, Huiyan Jiang
BACKGROUND: Positron emission tomography (PET) is extensively employed for diagnosing and staging various tumors, including liver cancer, lung cancer, and lymphoma. Accurate subtype classification of tumors plays a crucial role in formulating effective treatment plans for patients. Notably, lymphoma comprises subtypes like diffuse large B-cell lymphoma and Hodgkin's lymphoma, while lung cancer encompasses adenocarcinoma, small cell carcinoma, and squamous cell carcinoma. Similarly, liver cancer consists of subtypes such as cholangiocarcinoma and hepatocellular carcinoma...
April 9, 2024: Computers in Biology and Medicine
https://read.qxmd.com/read/38626175/the-immunoregulatory-effects-of-total-glucosides-of-paeony-in-autoimmune-diseases
#28
JOURNAL ARTICLE
Mengna Zhao, Na Peng, Yingbo Zhou, Yuan Qu, Meng Cao, Qinghua Zou, Qinghong Yu, Liwei Lu, Fan Xiao
Total glucoside of paeonia (TGP) and its main active ingredient paeoniflorin, extracted from the Chinese herb Paeonia Lactiflora Pallas, exhibit potent immunomodulatory effects. TGP has been shown to inhibit inflammatory responses and disease progression in experimental models of multiple autoimmune diseases (AIDs), including rheumatoid arthritis, systemic lupus erythematosus, Sjogren's syndrome, psoriasis, etc. TGP shows broad immunomodulatory effects on many immune cells such as T cells, macrophages, and dendritic cells, by regulating their activation, proliferation, differentiation, and production of effector molecules...
April 16, 2024: Journal of Leukocyte Biology
https://read.qxmd.com/read/38625989/global-burden-of-rheumatoid-arthritis-among-adolescents-and-young-adults-aged-10-24-years-a-trend-analysis-study-from-1990-to-2019
#29
JOURNAL ARTICLE
Ruibo Li, Xingyue Yuan, Yili Ou
BACKGROUND: In recent decades, there has been a global increase in the burden of rheumatoid arthritis (RA) among adolescents and young adults (AYAs), making it a significant public health issue. However, our understanding of the disease burden, harm, and influencing factors of RA in this population remains insufficient. This study aimed to assess the trends in RA burden among AYAs aged 10-24 years from 1990 to 2019 at the global, regional, and national levels. METHODS: Incidence, prevalence, and disability-adjusted life years (DALYs) rate per 100,000 population, as well as average annual percentage changes (AAPCs), of RA among individuals aged 10-24 years were reported globally, regionally, and nationally based on the Global Burden of Diseases, Injuries, and Risk Factors Study 2019 (GBD 2019)...
2024: PloS One
https://read.qxmd.com/read/38623016/-l-dep-regimen-salvage-therapy-for-refractory-primary-hemophagocytic-lymphohistiocytosis-triggered-by-epstein-barr-virus-infection-in-4-children
#30
JOURNAL ARTICLE
Y Z Zhao, H H Ma, H Y Lian, D Wang, T Y Wang, R Zhang
Objective: To analyze the efficacy and safety of the L-DEP regimen (asparaginase, liposome doxorubicin, etoposide and methylprednisolone) as a salvage therapy for the refractory primary hemophagocytic lymphohistocytosis triggered by Epstein-Barr virus infection (EBV-pHLH) in children. Methods: In this retrospective case study, clinical and laboratory data before and after L-DEP regimen of 4 children diagnosed with EBV-pHLH in Beijing Children's hospital between January 2016 and June 2022 were collected, and the efficacy and safety of L-DEP regimen for the treatment of EBV-pHLH were analyzed...
April 16, 2024: Zhonghua Er Ke za Zhi. Chinese Journal of Pediatrics
https://read.qxmd.com/read/38622428/evaluation-of-inflammatory-biomarkers-and-the-ratio-of-hemoglobin-red-cell-distribution-width-in-patients-with-rheumatoid-arthritis-treated-with-tumor-necrosis-factor-alpha-inhibitors
#31
JOURNAL ARTICLE
Ayşegül Yetişir, Aylin Sariyildiz, İpek Türk, Ilke Coskun Benlidayi
BACKGROUND: The aim of this study was to examine pre-treatment and post-treatment hemogram-derived inflammatory biomarkers in patients with rheumatoid arthritis (RA) who received anti-tumor necrosis factor (TNF)-α treatment. MATERIAL AND METHODS: The data of 1182 patients with RA were screened. Among them, 207 patients who met the eligibility criteria were included in the retrospective study. Demographic parameters, disease activity, and blood cell-derived indexes were evaluated...
April 15, 2024: Clinical Rheumatology
https://read.qxmd.com/read/38622198/loss-of-srebp-1c-ameliorates-iron-induced-liver-fibrosis-by-decreasing-lipocalin-2
#32
JOURNAL ARTICLE
Eun-Ho Lee, Jae-Ho Lee, Do-Young Kim, Young-Seung Lee, Yunju Jo, Tam Dao, Kyung Eun Kim, Dae-Kyu Song, Ji Hae Seo, Young-Kyo Seo, Je Kyung Seong, Changjong Moon, Eugene Han, Mi Kyung Kim, Seungwan Ryu, Minsang Shin, Gu Seob Roh, Hye Ra Jung, Timothy F Osborne, Dongryeol Ryu, Tae-Il Jeon, Seung-Soon Im
Sterol regulatory element-binding protein (SREBP)-1c is involved in cellular lipid homeostasis and cholesterol biosynthesis and is highly increased in nonalcoholic steatohepatitis (NASH). However, the molecular mechanism by which SREBP-1c regulates hepatic stellate cells (HSCs) activation in NASH animal models and patients have not been fully elucidated. In this study, we examined the role of SREBP-1c in NASH and the regulation of LCN2 gene expression. Wild-type and SREBP-1c knockout (1cKO) mice were fed a high-fat/high-sucrose diet, treated with carbon tetrachloride (CCl4 ), and subjected to lipocalin-2 (LCN2) overexpression...
April 16, 2024: Experimental & Molecular Medicine
https://read.qxmd.com/read/38621928/-mechanism-of-yuxuebi-tablets-in-treating-synovial-inflammation-in-rheumatoid-arthritis-based-on-transcriptomics
#33
JOURNAL ARTICLE
Xin-Zhuo Zhang, Xue-Ying Tao, Feng-Yu Huang, Pan-Pan Zhu, Bei Yuan, Pei-Ping Chen, Xiang-Ying Kong, Na Lin, Xiao-Hui Su
This study investigated the mechanism of Yuxuebi Tablets(YXB) in the treatment of synovial inflammation in rheumatoid arthritis(RA) based on transcriptomic analysis. Transcriptome sequencing technology was employed to analyze the gene expression profiles of joint tissues from normal rats, collagen-induced arthritis(CIA) rats(an RA model), and YXB-treated rats. Common diffe-rentially expressed genes(DEGs) were subjected to Gene Ontology(GO) and Kyoto Encyclopedia of Genes and Genomes(KEGG) enrichment analyses...
March 2024: Zhongguo Zhong Yao za Zhi, Zhongguo Zhongyao Zazhi, China Journal of Chinese Materia Medica
https://read.qxmd.com/read/38621927/-mechanism-of-bulleyaconitine-a-in-inhibiting-bone-destruction-of-rheumatoid-arthritis-via-src-pi3k-akt-signaling-pathway
#34
JOURNAL ARTICLE
Feng-Yu Huang, Wan-Yi Guo, Pei-Ping Chen, Xin-Zhuo Zhang, Zhuo-Hang Li, He-Lan Huang, Na Lin, Xiao-Hui Su, Xiang-Ying Kong
Based on the sarcoma receptor coactivator(Src)/phosphatidylinositol 3-kinase(PI3K)/protein kinase B(Akt) signaling pathway, the mechanism of action of bulleyaconitine A in the treatment of bone destruction of experimental rheumatoid arthritis(RA) was explored. Firstly, key targets of RA bone destruction were collected through GeneCards, PharmGKB, and OMIM databa-ses. Potential targets of bulleyaconitine A were collected using SwissTargetPrediction and PharmMapper databases. Next, intersection targets were obtained by the Venny 2...
March 2024: Zhongguo Zhong Yao za Zhi, Zhongguo Zhongyao Zazhi, China Journal of Chinese Materia Medica
https://read.qxmd.com/read/38621793/upadacitinib-in-rheumatoid-arthritis-and-inadequate-response-to-conventional-synthetic-disease-modifying-antirheumatic-drugs-efficacy-and-safety-through-5-years-select-next
#35
JOURNAL ARTICLE
Gerd R Burmester, Filip Van den Bosch, John Tesser, Anna Shmagel, Yanxi Liu, Nasser Khan, Heidi S Camp, Alan Kivitz
OBJECTIVE: To report 5-year efficacy and safety of upadacitinib in rheumatoid arthritis (RA) from the phase 3 long-term extension (LTE) of SELECT-NEXT. METHODS: Patients on stable conventional synthetic disease-modifying antirheumatic drugs were randomized to upadacitinib 15 mg, upadacitinib 30 mg once daily (UPA15/30), or placebo for 12 weeks. Following this, placebo-randomized patients were switched to UPA15 or UPA30 in the LTE; upadacitinib-randomized patients continued their original dose...
April 15, 2024: Journal of Rheumatology
https://read.qxmd.com/read/38621248/rheumatology-what-you-may-have-missed-in-2023
#36
JOURNAL ARTICLE
Kafaf Jalali, Lisa A Mandl
Many patients with rheumatologic conditions receive care from physicians other than rheumatologists. Here we note key findings from 6 studies in rheumatology published in 2023 that offer valuable insights for internal medicine specialists and subspecialists outside of rheumatology. The first study investigated the effect of low-dose glucocorticoids on patients with rheumatoid arthritis (RA) over 2 years and challenged existing perceptions about the risks of glucocorticoids in this setting. The second study focused on the updated guideline for preventing and treating glucocorticoid-induced osteoporosis...
April 16, 2024: Annals of Internal Medicine
https://read.qxmd.com/read/38618740/efficacy-of-genotype-matched-vaccine-against-re-emerging-genotype-v-japanese-encephalitis-virus
#37
JOURNAL ARTICLE
Jae-Deog Kim, Ah-Ra Lee, Dah-Hyun Moon, Young-Uk Chung, Su-Yeon Hong, Hyo Je Cho, Tae Hyun Kang, Yo Han Jang, Myung Hyun Sohn, Baik-Lin Seong, Sang-Uk Seo
Japanese encephalitis (JE), caused by the Japanese encephalitis virus (JEV), is a highly threatening disease with no specific treatment. Fortunately, the development of vaccines has enabled effective defense against JE. However, re-emerging genotype V (GV) JEV poses a challenge as current vaccines are genotype III (GIII)-based and provide suboptimal protection. Given the isolation of GV JEVs from Malaysia, China, and the Republic of Korea, there is a concern about the potential for a broader outbreak. Under the hypothesis that a GV-based vaccine is necessary for effective defense against GV JEV, we developed a pentameric recombinant antigen using cholera toxin B as a scaffold and mucosal adjuvant, which was conjugated with the E protein domain III of GV by genetic fusion...
April 15, 2024: Emerging Microbes & Infections
https://read.qxmd.com/read/38618407/epstein-barr-virus-positive-mucocutaneous-ulcer-on-the-gingiva-of-a-patient-in-whom-immunosuppressive-drugs-could-not-be-withdrawn-a-case-report-and-review-of-the-literature
#38
Tatsuya Sakaguchi, Shunichi Yoshida, Takeshi Karube, Taneaki Nakagawa, Seiji Asoda
Epstein-Barr virus-positive mucocutaneous ulcer (EBV-MCU) is characterized by ulcers confined to the skin and mucus membranes. EBV-MCU is an EBV-positive lymphoproliferative disorder that occurs during the use of immunosuppressive drugs such as methotrexate. We herein report a case of EBV-MCU in the maxillary gingiva. A 73-year-old woman was referred to our department in March 2021. During the initial examination, bone exposure and ulceration were observed in the extraction socket of the maxillary bilateral central incisors...
March 2024: Curēus
https://read.qxmd.com/read/38618292/-18-f-fluorodeoxyglucose-uptake-by-positron-emission-tomography-in-patients-with-ipah-and-cteph
#39
JOURNAL ARTICLE
Celik Sumer, Gulfer Okumus, Emine Goknur Isik, Cuneyt Turkmen, Ahmet Kaya Bilge, Murat Inanc
Pulmonary arterial hypertension (PAH) is driven by pathologies associated with increased metabolism such as pulmonary revascularization, vasoconstriction and smooth muscle cell proliferation in pulmonary artery wall. 18-fluorodeoxyglucose positron emission tomography (18FDG-PET) is an imaging technique sensitive to glucose metabolism and might be considered as a non-invasive method for diagnosis due to significant role of inflammation in idiopathic pulmonary artery hypertension (IPAH) and chronic thromboembolic pulmonary hypertension (CTEPH)...
April 2024: Pulmonary Circulation
https://read.qxmd.com/read/38617532/cysltr1-antagonist-inhibits-th17-cell-differentiation-by-regulating-the-nf-%C3%AE%C2%BAb-signaling-for-the-treatment-of-psoriasis
#40
JOURNAL ARTICLE
Junpeng Zhao, Yi Chen, Liming Li, Huiqi Yin, Shasha Song, Yongfang Wang, Xiwei Feng, Xinyu Fan, Changxing Gao, Lingyu Gao, Yijing Zhan, Ming Zhao, Xinyu Li, Qianjin Lu
Cysteinyl leukotriene receptor 1 (CYSLTR1) is observed to increase in psoriatic skin lesions. Montelukast, a CYSLTR1 antagonist, effectively treats inflammatory disorders, such as rheumatoid arthritis, multiple sclerosis, and atopic dermatitis. Thus, blocking CYSLTR1 may be a promising strategy for psoriasis immunotherapy. We prepared a montelukast sodium cream and solution and investigated their effects on psoriasis-like skin lesions induced by imiquimod (IMQ). After the treatment, serum, skin, and spleen samples were collected for evaluation...
2024: International Journal of Biological Sciences
keyword
keyword
91514
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.